Tasly Pharmaceutical Group Co., Ltd
600535.SS · SHH
Market closed15.38-0.550000 (-3.45%)
Key statistics
Previous close15.93
Open15.90
Day high15.95
Day low15.38
52-week high17.69
52-week low12.90
Market cap22.98B
Volume25.50M
Average volume12.43M
P/E ratio22.28
Forward P/E—
EPS0.69
Dividend yield+2.02%
Market context
Why it moved
Shares of 600535.SS (Tasly Pharmaceutical) declined notably today amid broad selling pressure in the Chinese healthcare sector, as investor sentiment weakened on concerns over regulatory scrutiny and pricing pressures on domestic pharmaceutical companies.
What is happening
Recent company-specific developments and publisher coverage.
TradingView · July 16, 2026Tasly Pharmaceutical Prelim H1 Net Profit Up 15.2% Y/Ywww.marketscreener.com · July 14, 2026Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026GlobeNewswire · March 30, 2026AP Biosciences and Tasly Finalize Amended CollaborationBioPharma Dive · July 18, 2018Mesoblast gets access to China through deal with Tasly Mt Newswire · June 16, 2026Tasly Subsidiary Gets China Approval for Hypertension Drug Mt Newswire · June 9, 2026Tasly Gets China Approval for Traditional Insomnia Drops Mt Newswire · May 25, 2026China Approves Tasly Pharmaceutical Subsidiary's Drug for Esophageal Irritation Mt Newswire · April 27, 2026Tasly Pharmaceutical's Profit Rises 18% in Q1; Shares Up 3% Mt Newswire · March 20, 2026Tasly Pharmaceutical's Profit Rises 16% in 2025 Mt Newswire · March 20, 2026Tasly Pharmaceutical Signs Cooperation Deal for CAR-T Drug Mt Newswire · February 9, 2026Tasly Pharmaceutical Ends Deal to Grant Arbor Pharma Rights to Compound Danshen Dripping Pills Mt Newswire · February 9, 2026Tasly Pharmaceutical's Profit Rises 16% in 2025